Symptom Tracker

Start Tracking Your Symptoms

Understand More About Your Irritable Bowel Syndrome with Constipation (IBS-C)

Track

Record your experiences daily using the tracking table

Monitor

Refer to your past entries to help you measure patterns or changes over time

Discuss

Review your completed Symptom Tracker with your healthcare provider to understand more about what you are experiencing

Short on time?

Download a non-personalized version of the tracker

Get Started Here:

Please complete the following form to personalize your Symptom Tracker:

First Name:
How long do you want to track your symptoms?
When would you like to start tracking?	Today \| Tomorrow

YES! Sign me up for free emails from AMITIZA filled with helpful information.

Providing the following information ensures that we send you the most relevant emails. All previous information provided for the Symptom Tracker will not be stored or otherwise associated with your email subscription.

* Indicates required information

*	First Name:
*	Last Name:
*	Email Address:

You must be 18 years of age or older to sign up.

*	Birthdate:
		MonthDayYear

*Gender
	Female
	Male

*Have you been diagnosed with IBS with Constipation?
	Yes
	No

*Are you currently taking AMITIZA?
	Yes
	No

I understand that by providing this information I am giving Takeda Pharmaceuticals North America, Inc., and their affiliates and business partners, permission to use my personal information to provide me with information and offers related to AMITIZA, the diseases and conditions it treats, and related treatments. I understand I may revoke my permission at any time by clicking here.

To learn how Takeda will use and protect your personal information please review our
Privacy Policy.

Indication

AMITIZA (8 mcg) twice daily is approved to treat Irritable Bowel Syndrome with Constipation (IBS-C) in women 18 years of age and older.

Important Safety Information

AMITIZA is not for everyone. If you know or suspect you have a bowel blockage, do not take AMITIZA. If you are unsure, your healthcare provider should evaluate your condition before starting AMITIZA. You should not take AMITIZA if you have severe diarrhea.

AMITIZA has not been studied in pregnant women and should only be used during a pregnancy if the potential benefits justify the potential risk to the fetus. Women should have a negative pregnancy test before beginning treatment with AMITIZA and need to practice effective birth control measures. If you are pregnant or become pregnant while being treated with AMITIZA, talk to your healthcare provider to evaluate the risks to the fetus.

Some patients taking AMITIZA may experience nausea or diarrhea. If nausea occurs, take AMITIZA with food. If your nausea or diarrhea becomes severe, tell your healthcare provider.

Within an hour of taking AMITIZA, a sensation of chest tightness and shortness of breath may occur. These symptoms usually go away within three hours, but may recur with repeated use. Tell your healthcare provider if you experience these symptoms.

The most common side effects of taking AMITIZA (8 mcg) twice daily, pink capsules for IBS-C are nausea, diarrhea, and abdominal pain. These are not all the side effects associated with AMITIZA.

Tell your doctor if you have liver problems.

Please click here for complete Prescribing Information.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.